Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

Quantitation of HMG-CoA reductase mRNA levels in peripheral blood mononuclear cells of normal individuals and patients with altered lipoprotein metabolism.

Alrokayan SA, Marenah CB, White DA, Billett MA.

Biochem Soc Trans. 1993 Nov;21(4):375S. No abstract available.

PMID:
8131952
3.

Measurement of mRNA by quantitative PCR with a nonradioactive label.

Powell EE, Kroon PA.

J Lipid Res. 1992 Apr;33(4):609-14.

4.
5.

Diagnosing familial hypercholesterolaemia in childhood.

Betteridge DJ, Galton D, Giggins M.

Br Med J. 1977 Jul 9;2(6079):127. No abstract available.

6.

Study of cytochrome P4502E1 mRNA level of mononuclear cells in patients with alcoholic liver disease.

Yano H, Tsutsumi M, Fukura M, Chen WB, Shimanaka K, Tsuchishima M, Takase S, Imaoka S, Funae Y.

Alcohol Clin Exp Res. 2001 Jun;25(6 Suppl):2S-6S.

PMID:
11410732
7.

Diurnal and dietary-induced changes in cholesterol synthesis correlate with levels of mRNA for HMG-CoA reductase.

Jurevics H, Hostettler J, Barrett C, Morell P, Toews AD.

J Lipid Res. 2000 Jul;41(7):1048-54.

8.

Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters.

Feingold KR, Hardardottir I, Memon R, Krul EJ, Moser AH, Taylor JM, Grunfeld C.

J Lipid Res. 1993 Dec;34(12):2147-58.

11.
12.

Cell growth and cholesterol metabolism in human glucose-6-phosphate dehydrogenase deficient lymphomononuclear cells.

Batetta B, Bonatesta RR, Sanna F, Putzolu M, Mulas MF, Collu M, Dessì S.

Cell Prolif. 2002 Jun;35(3):143-54.

PMID:
12027950
14.
15.

Regulation of low density lipoprotein receptor and 3-hydroxy-3-methyl-glutaryl-CoA reductase activities are differentially affected in Niemann-Pick type C and type D fibroblasts.

Sidhu HS, Rastogi SA, Byers DM, Guernsey DL, Cook HW, Palmer FB, Spence MW.

Biochem Cell Biol. 1993 Sep-Oct;71(9-10):467-74.

PMID:
8192899
16.

Hyperexpression of low-density lipoprotein receptors and hydroxy-methylglutaryl-coenzyme A-reductase in human pinguecula and primary pterygium.

Peiretti E, Dessì S, Putzolu M, Fossarello M.

Invest Ophthalmol Vis Sci. 2004 Nov;45(11):3982-5.

PMID:
15505045
17.

The novel cholesterol-lowering drug SR-12813 inhibits cholesterol synthesis via an increased degradation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

Berkhout TA, Simon HM, Patel DD, Bentzen C, Niesor E, Jackson B, Suckling KE.

J Biol Chem. 1996 Jun 14;271(24):14376-82.

18.

Increased cholesterol biosynthesis and hypercholesterolemia in mice overexpressing squalene synthase in the liver.

Okazaki H, Tazoe F, Okazaki S, Isoo N, Tsukamoto K, Sekiya M, Yahagi N, Iizuka Y, Ohashi K, Kitamine T, Tozawa R, Inaba T, Yagyu H, Okazaki M, Shimano H, Shibata N, Arai H, Nagai RZ, Kadowaki T, Osuga J, Ishibashi S.

J Lipid Res. 2006 Sep;47(9):1950-8. Epub 2006 Jun 1.

19.

Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells.

Morikawa S, Umetani M, Nakagawa S, Yamazaki H, Suganami H, Inoue K, Kitahara M, Hamakubo T, Kodama T, Saito Y.

J Atheroscler Thromb. 2000;7(3):138-44.

PMID:
11480454
20.

Control of cholesterol biosynthesis in Schwann cells.

Fu Q, Goodrum JF, Hayes C, Hostettler JD, Toews AD, Morell P.

J Neurochem. 1998 Aug;71(2):549-55.

Supplemental Content

Support Center